NEW YORK (GenomeWeb News) – Agilent Technologies has signed a co-marketing agreement with Life Technologies related to targeted resequencing, an Agilent official said today.

Speaking at the UBS Global Life Sciences Conference, Nick Roelofs, president of Agilent's Life Sciences Group, said that the company has signed an agreement with Life Technologies to co-market Agilent's SureSelect Target Enrichment System with the Applied Biosystems SOLiD sequencing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.